Ista Pharmaceuticals, Inc. (ISTA) Tops Q4 EPS by 4c, Sales Miss Expectations
Tweet
Share
E-mailGet Alerts ISTA Hot Sheet
Price: $9.09 --0%
Financial Fact:
Income (loss) from operations: -1.61M
Today's EPS Names:
CHA, EDXC, YAYO, More
Financial Fact:
Income (loss) from operations: -1.61M
Today's EPS Names:
CHA, EDXC, YAYO, More
Join SI Premium – FREE
Ista Pharmaceuticals, Inc. (NASDAQ: ISTA) reported Q4 EPS of $0.25, $0.04 better than the analyst estimate of $0.21. Revenue for the quarter came in at $45.1 million versus the consensus estimate of $46.55 million.
For earnings history and earnings-related data on Ista Pharmaceuticals, Inc. (ISTA) click here.
For earnings history and earnings-related data on Ista Pharmaceuticals, Inc. (ISTA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blue Owl leads $2.4 billion debt deal for Iren data center
- Chile's Codelco posts stronger profit on copper rally as mine disruptions drag on output
- Hub Group faces credibility test as Q2 report looms Sept. 1
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
